Latest Volition News & Updates

See the latest news and media coverage for Volition. We track all announcements, press releases, and industry mentions in real time, all in one place.

Volition

Epigenetic diagnostics company

volition.com

Headquarters: Henderson, United States
Founded year: 2010
Company type: Public company
Number of employees: 70–200
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Volition

In short: Volition reported first-half revenue growth, achieved clinical validation for its sepsis biomarker, and advanced licensing with Sysmex.

Company announcements

August 26 Volition

Volition highlights commercial momentum across major addressable markets

The organization recently published a press release detailing execution strategies targeting extensive global opportunities.

August 26 Volition

Volition announces Nu.Q NETs biomarker clinical validation for sepsis

The organization highlights this breakthrough as a critical step toward improving early patient detection and guiding targeted therapeutic interventions.

August 13 Volition

Volition announces second quarter 2026 financial results and business updates

The company reported $1.4 million in first-half revenue, reduced operating expenses by 32 percent, and raised over $5 million through equity sales during the period.

July 30 Volition

Volition advances its Nu.Q NETs platform toward commercialization

Clinical data confirms accurate sepsis detection through elevated H3.1 nucleosome levels. Leadership currently negotiates partnerships with major diagnostic firms to exploit this thirty eight billion dollar opportunity.

Media coverage

August 27 Yahoo Finance

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations

VolitionRx Limited (NYSE:VNRX) stock is surging on Thursday after the diagnostics company reported a 112% year-over-year revenue surge in the first half of 2026, reaching...

August 26 PR Newswire

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets

/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today provides a comprehensive corporate update...

August 26 Yahoo Finance

Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the publication of a peer-reviewed paper and independent Editorial which reported that its...

August 25 TipRanks

VolitionRx Continues Debt Conversion Via Equity Issuances - TipRanks.com

VolitionRx Limited disclosed that, under a previously negotiated securities purchase agreement with Lind Global Asset Management XII LLC, it has been issuing shares of common...

Never miss news about Volition

Track Volition and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Volition competitors & trending companies

Browse news for competitors to Volition and other trending companies.